A groundbreaking approach to mental health treatment is offering a glimmer of hope for those struggling with mental health issues and their impact on work. The power of metacognitive therapy and its focus on the job could be a game-changer, saving both time and money.
In Norway, where sick leave due to mental illness is on the rise, this innovative treatment method is making waves. Odin Hjemdal, a professor and psychology specialist at the Norwegian University of Science and Technology, believes it's a game-changer. "Metacognitive therapy, combined with a job-focused approach, can get people back to work faster," he asserts.
The results of a recent study, published in the high-impact journal eClinicalMedicine, a part of the Lancet family, back up Hjemdal's claims. The study involved 236 individuals on sick leave, and the findings are eye-opening. Around half of the participants received early treatment, and the impact was significant. "The savings in reduced sick leave costs for this group alone amounted to approximately NOK 9.5 million," Hjemdal explains.
But here's where it gets controversial: the early treatment group saw 42% of participants return to work after 12 weeks, compared to just 18% in the group that had to wait for treatment. However, those who waited still achieved good results once they received the therapy. So, the question arises: could early intervention make a bigger difference than we realize?
The potential savings are immense. In 2017, Norway had 223,000 people on sick leave due to mental disorders, and by 2024, this number had soared to 327,000, an increase of nearly 47%. With such a substantial rise, the benefits of an effective treatment are clear.
But what exactly is metacognitive therapy, and how does it work?
"Metacognitive therapy doesn't focus on the content of your thoughts; instead, it's about how you relate to them," Hjemdal clarifies. In essence, it's about teaching individuals to let their thoughts and feelings come and go without getting caught up in regulating them. This approach, developed by Professor Adrian Wells, is structured and short-term, and it's proven effective for anxiety and depression, with a high recovery rate and low relapse.
Job focus, an integral part of the therapy, emphasizes the importance of work for mental health. Therapists explore the individual's job situation, any needed accommodations, and obstacles to returning to work, such as workplace bullying. By addressing these issues, the therapy aims to help individuals return to their normal lives swiftly.
And this is the part most people miss: the treatment seems particularly promising for anxiety and depression, two of the main reasons for sick leave in Norway. "Sick leave related to anxiety and depression costs Norway approximately NOK 71 billion annually," Hjemdal points out.
So, could this be the solution we've been searching for? With the potential to save both suffering and money, metacognitive therapy and its job-focused approach offer a ray of hope. But what do you think? Is this the future of mental health treatment, or are there potential pitfalls we should consider? We'd love to hear your thoughts in the comments!
